Antitumor and Antiviral Nucleoside Analogues
$216,344R01FY2002CANIH
Wayne State University, Detroit MI
Investigators
Linked publications & trials
Paper 27139481Paper 23817384Paper 20846508Paper 20547817Paper 20183619Paper 19794230Paper 19410465Paper 19397271Paper 19333855Paper 18285481Paper 18082410Paper 17479434Paper 17454732Paper 17162591Paper 17004726Paper 16801980Paper 16758001Paper 15728900Paper 15634003Paper 15615545Paper 15561852Paper 14736238Paper 14565285Paper 14561099Paper 12744601Paper 12495213Paper 12161159Paper 12084469Paper 11689090Paper 11563045Paper 10993343Paper 10901290Paper 10817700Paper 10814087Paper 10772701Paper 10739880
Abstract
DESCRIPTION (provided by applicant): New nucleoside and nucleotide analogues will be prepared and studied as antiviral antitumor agents.These compounds will include (i) gem-bis-(hydroxymethyl)methylenecyclopropanes, (ii) cyclicphosphates of gem-bis-(hydroxymethyl) methylenecyclopropanes, (iii) lipophilic phosphoralaninate prodrugs of gem-bis-(hydroxymethyl)methylenecyclopropanes, (iv) 7-(2-amino)purine analogues, (v) phosphonateanalogues of methylenecyclopropanes and (vi) resolution of R and S diastereoisomers of phosphoralaninate methylenecyclopropane prodrugs,synthesis of the respective phosphorothioates and study of stereochemistry of intracellular activation.
View original record on NIH RePORTER →